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Cervical cancer is an important public health
problem among adult women in Nigeria and other
developing countries. It is estimated that there are
about 25,000 new cases in Nigeria every year , and
most present late. About 231,000 or more deaths
occur annually due to cancer of the cervix
worldwide . Cervical cancer is one of the few
preventable cancers since it has a clear pre- cancer
stage. Regular cytological screening programmes
either organized or opportunistic have led to decline
in cervical cancer incidence and mortality in the
developed countries. Papinicolaou (Pap) smear for
many years has been the gold standard and has led to
a reduction in incidence of cervical cancer in Europe
and North America . Alternative methods of
screening especially in resource limited settings
such as visual inspection with acetic acid or Lugol's
iodine are being promoted. . An earlier study on
risk factors for cervical cancer among women inAba
identified several risk factors predisposing to
cervical cancer which included: early age of
initiation of sexual activity, multiple sexual partners
and previous history of sexually transmitted
disease. other risk factors include smoking and use
of steroidal oral contraceptive methods. In a
community such as ours with these confirmed
prevalent risk factors predisposing to cervical
cancer, it is considered important to determine the
antenatal women's knowledge of cervical cancer,
screening with papinicolaous smear test as well the
utilization of the Pap smear test. It is hoped that the
findings of this study will prove useful during the
organization of an intervention programme to
sensitize the community about cancer of the cervix
and its prevention. This was a hospital; based
descriptive study done between 1 June, 2007 and
15 June, 2007 at the ante-natal clinic of the Abia
State University Teaching Hospital, Aba. 100
consecutive antenatal women who gave informed
consent to participate in the study were enrolled. A
structured questionnaire was administered to elicit
demographic data, knowledge of cervical cancer,
cervical cancer screening with pap smear test as
wellas the utilization of the test. Data analysis
included descriptive statistics for demographicdata
and content analysis for interview data. Ethical
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Abia State University teaching hospitalAba.A total of
100 consecutive antenatal clinic attendees were
recruited for the study. Table 1 shows the socio-
demographic characteristics. Two participants were
teenagers, fifty were between 20-29 years old, forty-
six were between 30 and 39 years old and two were
between 40 and 49 years old. Majority of the study
women (98%) were married. Four (4%) of the
respondents had learned about pap smear and none
knew what Pap smear screened for. None of the
respondents had ever had a pap smear taken before.
Thirty (30%) of the respondents had heard of the
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Variable No. Percentage (%)
< 19 2 2
20 - 29 50 50
30 -39 46 46






Post - Secondary 50 50





Awareness of Pap Smear
Yes 4 4
No 96 96
Have had Pap Smear Test in the Past.
Yes 0 0
No 100 100
Awareness of what Pap Smear Screens for.
Yes 0 0
No 100 100
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Research Letter
Early detection of cervical cancer has reduced the
mortality and morbidity of cervical cancer world
wide, and it has been reported that both organized and
opportunistic Pap smear taking has lowered
incidence rates of cervical cancer. . In our study
population only 4% of the women had heard about
Pap smears. This is lower than 19.7% of Ibadan
market women, who had heard about pap smear as
well as 16% of rural Kenyan women who had heard
about Pap smear . None of the women in our study
had ever had a pap smear taken whilst 5.2% and 2.1%
had ever had a pap smear taken in the Ibadan and
Kenyan studies respectively. . These figures denote
none and low utilization of the pap smear test in these
African women in Nigeria and Kenyan. Only 30% of
the women studied, had knowledge about the disease
called cervical cancer. This is lower than 41.8% of
women in the Ibadan study that had knowledge about
cervical cancer . Thus, knowledge of cervical cancer,
pap smears test and Pap smear utilization in this study
population was grossly inadequate. Studies
elsewhere have shown that factors such as lack of
knowledge about cervical screening contribute to low
levels of cervical screening as exemplified by our
study population. Further, cancer of the cervix is
expected to be highly prevalent here as other studies
have also shown that cancer of the cervix is most
common among poor communities with limited
facilities such as exist in Aba for screening for cancer
of the cervix. In interpreting these results, some
study limitations need to be considered. The sample
size was small as this was a baseline study. Studies
with much larger sample sizes in Aba and other
communities inAbia State are warranted.
In conclusion, this study has shown that knowledge
of cervical cancer and Pap smear test was inadequate
among the antenatal women studied. Pap smear
utilization was non existent. It is recommended that
appropriate health education on cancer of the cervix
and its prevention should be disseminated to Aba
women through public enlightenment campaign by
health care providers and the mass media. Organized
or opportunistic screening programmes for cervical
cancer is necessary inAba, South- Eastern Nigeria.
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